Thus, the purpose of this study was to estimate the differences of clinicopathologic features and prognosis between ER+/PR− phenotype and ER+/PR+ phenotype in IBC by analyzing the patients from Surveillance, Epidemiology and End Results (SEER) database. This evidence concerns the gene ESR1 and inflammatory breast carcinoma.